Deal Watch: Roivant Adds Ligand's Glucose Receptor Antagonist To Metavant Pipeline

 
• By Joseph Haas, Ian Haydock, Jung Won Shin, and John Davis
DealWatch_1200x675

More from Deals

More from Business